Achievements and obstacles of remyelinating therapies in multiple sclerosis
Achievements and obstacles of remyelinating therapies in multiple sclerosis
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
CNS remyelination serves to limit and repair the damage in demyelinating diseases such as multiple sclerosis (MS)
Several intrinsic molecular pathways that execute endogenous remyelination have been identified and are potential therapeutic targets
The first clinical proof-of-concept trials to enhance remyelination in MS have bee...
Alternative Titles
Full title
Achievements and obstacles of remyelinating therapies in multiple sclerosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1966240354
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1966240354
Other Identifiers
ISSN
1759-4758
E-ISSN
1759-4766
DOI
10.1038/nrneurol.2017.139
